Delivery Order SPE2DB24D3015-SPE2DB24FFXQD
Award Date
9/4/24
Potential Completion Date
9/5/24
Potential Value
$6.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) was issued by the Defense Logistics Agency (DLA) for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. It is a firm fixed price delivery order with a ceiling value of $2,377.45 and a completion date of October 9, 2024. The contract is not set aside for any specific business category. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The delivery order has a firm fixed price of $74,904.80 and a completion date of September 20, 2024. The award is not associated with a set-aside program. As a leading provider of pharmaceutical and medical supplies to the U.S. federal government, Amerisourcebergen holds significant...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has a ceiling value of $5,131.80 and a period of performance through July 9, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine, with a ceiling value of $6,906.32 and a period of performance through March 12, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,733.76, is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has an ultimate completion date of June 6, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This contract is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with a ceiling value of $2,105.78 and a completion date of May 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. As a major supplier of pharmaceutical products to federal...
This federal contract award is a delivery order with a ceiling value of $6,684.23, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with an ultimate completion date of August 6, 2024. The contract is a firm fixed-price arrangement, and there was no set-aside used. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has a ceiling value of $46,339.37 and a period of performance through January 22, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The order has a ceiling value of $5,617.86 and a performance period ending on March 26, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this order, which is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has a ceiling value of $3,453.20 and is a firm fixed price, non-set-aside contract with a completion date of June 25, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...